Skip to main content
logo
Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
3.920
-0.300 (-7.11%)
Oct 23, 2026, 4:00 PM EDT - Market closed

Adial Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-57.8-7.98-13.2-5.12-12.73-19.42
Depreciation & Amortization
000000.06
Asset Writedown & Restructuring Costs
46.19----1.55
Loss (Gain) on Equity Investments
0.480.490.550.19--
Stock-Based Compensation
0.60.680.81.753.374.24
Other Operating Activities
-0.16-0.154.54-1.831.940.17
Change in Accounts Payable
1.640.360.17-0.160.02-0.35
Change in Other Net Operating Assets
-2.080.110.22-0.63-1.191.82
Operating Cash Flow
-11.13-6.49-6.92-6.81-11.19-11.95
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
------0.06
Sale of Property, Plant & Equipment
---1.5--
Cash Acquisitions
5.28----0.03
Other Investing Activities
-0.15----
Investing Cash Flow
5.280.15-1.5--0.03

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
4.298.477.850.759.1313.64
Repurchase of Common Stock
----0--
Other Financing Activities
24.36--3.38--
Financing Cash Flow
28.658.477.854.139.1313.64

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
22.82.130.92-1.17-2.061.66

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-11.13-6.49-6.92-6.81-11.19-12.01
Free Cash Flow Growth
------
Free Cash Flow Per Share
-4.24-9.71-35.67-119.45-279.23-403.94
Levered Free Cash Flow
-3.93-3.77-3.99-3.29-4.67-5.33
Unlevered Free Cash Flow
-2.64-3.77-3.99-3.29-4.67-5.33

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.440.470.39-0.79-1.171.46
SEC Filings: 10-K · 10-Q